Djordje Knezevic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Djordje Knezevic has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Srbislav Knezevic
4 shared publications- Igor Ignjatovic
Clinical Centre of Serbia, Clinic for Digestive Surgery, Department for Hepato-Pancreato-Biliary Surgery, Belgrade, Serbia + University of Belgrade, Faculty of Medicine, Department for Surgery, Belgrade, Serbia
3 shared publications Marjan Micev
Clinical Center of Serbia, Clinic for Digestive Surgery, Belgrade
3 shared publications- Slavko Matic
Clinical Centre of Serbia, Clinic for Digestive Surgery - First Surgical Clinic, Belgrade, Serbia + University of Belgrade, Faculty of Medicine, Belgrade, Serbia
3 shared publications Srbislav M Knezevic
2 shared publicationsVladimir Dugalic
Srbislav Knezevic, Igor Ignjatovic, Slavko Matic, Vladimir Dugalic, Djordje Knezevic, Clinic for Digestive Surgery-First Surgical Clinic, Clinical Center of Serbia, University of Belgrade, 11000 Belgrade, Serbia
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Medicinska istrazivanja
- No. 00,p. 14
Preoperative health-related quality of life in patients undergoing elective surgery for colorectal cancer
Introduction: Health-related quality of life (HRQoL) is an important multidimensional, patient-centered concept in colorectal cancer (CRC). However, data on preoperative HRQoL in Southeast European surgical populations remain limited. This study aimed to describe preoperative HRQoL in patients undergoing elective surgery for CRC, compare HRQoL between colon and rectal cancer, and identify sociodemographic and clinical factors associated with preoperative HRQoL. Material and Methods: Preoperative HRQoL was assessed using the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) and the Cleveland Clinic Colorectal Cancer Quality of Life questionnaire (CCF-CaQL). Sociodemographic and clinical data were collected using a structured questionnaire and medical records. Group comparisons were performed by tumor localization, and factors associated with the FACT-C total score were evaluated using univariable and multivariable linear regression. Results: The mean CCF-CaQL total score was 92.3±20.4, and the mean FACT-C total score was 98.8±18.2. No significant differences in HRQoL were observed between patients with colon or rectal cancer across any questionnaire domains (all p > 0.05). In multivariable analysis, higher ASA physical status was independently associated with a lower FACT-C total score (B = -5.05; 95% CI = -9.70 to -0.40; p = 0.033). Conclusion: Preoperative HRQoL in patients undergoing elective CRC surgery was moderate and did not differ significantly by tumor localization. Higher ASA physical status was independently associated with poorer preoperative HRQoL.
- 1 January 2026
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Medicinska istrazivanja
- No. 00,p. 14
Open AccessPreoperative health-related quality of life in patients undergoing elective surgery for colorectal cancer
Introduction: Health-related quality of life (HRQoL) is an important multidimensional, patient-centered concept in colorectal cancer (CRC). However, data on preoperative HRQoL in Southeast European surgical populations remain limited. This study aimed to describe preoperative HRQoL in patients undergoing elective surgery for CRC, compare HRQoL between colon and rectal cancer, and identify sociodemographic and clinical factors associated with preoperative HRQoL. Material and Methods: Preoperative HRQoL was assessed using the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) and the Cleveland Clinic Colorectal Cancer Quality of Life questionnaire (CCF-CaQL). Sociodemographic and clinical data were collected using a structured questionnaire and medical records. Group comparisons were performed by tumor localization, and factors associated with the FACT-C total score were evaluated using univariable and multivariable linear regression. Results: The mean CCF-CaQL total score was 92.3±20.4, and the mean FACT-C total score was 98.8±18.2. No significant differences in HRQoL were observed between patients with colon or rectal cancer across any questionnaire domains (all p > 0.05). In multivariable analysis, higher ASA physical status was independently associated with a lower FACT-C total score (B = -5.05; 95% CI = -9.70 to -0.40; p = 0.033). Conclusion: Preoperative HRQoL in patients undergoing elective CRC surgery was moderate and did not differ significantly by tumor localization. Higher ASA physical status was independently associated with poorer preoperative HRQoL.
- Open Access
- 22 September 2025
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 30 (3) , 63-69
A Review of Introductal Papillary Mucinous Neoplasia Classification, Surgical Indications, and Outcomes
Intraductal papillary mucinous neoplasms (IPMNs) are pancreatic cystic lesions with malignant potential. This review outlines current guidelines, surgical indications, outcomes, and surveillance strategies. It also highlights recent advances in minimally invasive surgery and emerging biomarkers aimed at improving risk stratification and reducing unnecessary resections.
- 22 September 2025
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 30 (3) , 63-69
Open AccessA Review of Introductal Papillary Mucinous Neoplasia Classification, Surgical Indications, and Outcomes
Intraductal papillary mucinous neoplasms (IPMNs) are pancreatic cystic lesions with malignant potential. This review outlines current guidelines, surgical indications, outcomes, and surveillance strategies. It also highlights recent advances in minimally invasive surgery and emerging biomarkers aimed at improving risk stratification and reducing unnecessary resections.
- 1 June 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (3) , S86
Standard versus extended lymphadenectomy in radical surgical treatment for pancreatic head carcinoma
- 1 June 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (3) , S86
Standard versus extended lymphadenectomy in radical surgical treatment for pancreatic head carcinoma
- 6 November 2015
- Vol. 20 (5) , 1206-14
The importance of choice of resection procedures in T1 and T2 stage of carcinoma of the ampulla of Vater.
The ampulla of Vater (AV), with its strategic location and its remarkable predisposition to the development of various malignant tumors, makes it very challenging for surgery. In this study we aimed to examine the prognostic factors in the treatment of early-stage carcinoma of the AV as well as to contribute to the choice of optimal surgical procedure. We analyzed 109 AV patients, hospitalized at the Clinical Center of Serbia from January 1999 to December 2008 and we compared the clinicopathological features, analyzed intra- and postoperative data, recurrences and survival, according to duodenopancreatectomy (DP) or local resection (LR). DP was performed in 83 and LR in 26 patients. Overall survival (OS) was significantly influenced by the pathological (p) tumor stage (pT1/T2 vs pT3/T4), pathological nodal stage (pN0 vs pN1), perineural and vascular invasion, grade of tumor differentiation (G1 vs G3), and resection margin status (R0 vs R1). Kaplan-Meier analysis showed 64% 5-year overall survival of patients with pT1/T2 stage in the group with DP, and 58% in the group with LR (p>0.05). Survival analysis of pN1 patients in these two groups showed statistically significant difference (DP 49.67 vs LR 28.68 months, p0.05). Resection is mandatory for all proven AV tumors, and DP is the treatment choice. LR, due to reduced morbidity and mortality, might be recommended in elderly patients with comorbidities and in patients with stage pT1/T2, pN0 and well differentiated (G1,G2) tumors.
- 6 November 2015
- Vol. 20 (5) , 1206-14
The importance of choice of resection procedures in T1 and T2 stage of carcinoma of the ampulla of Vater.
The ampulla of Vater (AV), with its strategic location and its remarkable predisposition to the development of various malignant tumors, makes it very challenging for surgery. In this study we aimed to examine the prognostic factors in the treatment of early-stage carcinoma of the AV as well as to contribute to the choice of optimal surgical procedure. We analyzed 109 AV patients, hospitalized at the Clinical Center of Serbia from January 1999 to December 2008 and we compared the clinicopathological features, analyzed intra- and postoperative data, recurrences and survival, according to duodenopancreatectomy (DP) or local resection (LR). DP was performed in 83 and LR in 26 patients. Overall survival (OS) was significantly influenced by the pathological (p) tumor stage (pT1/T2 vs pT3/T4), pathological nodal stage (pN0 vs pN1), perineural and vascular invasion, grade of tumor differentiation (G1 vs G3), and resection margin status (R0 vs R1). Kaplan-Meier analysis showed 64% 5-year overall survival of patients with pT1/T2 stage in the group with DP, and 58% in the group with LR (p>0.05). Survival analysis of pN1 patients in these two groups showed statistically significant difference (DP 49.67 vs LR 28.68 months, p0.05). Resection is mandatory for all proven AV tumors, and DP is the treatment choice. LR, due to reduced morbidity and mortality, might be recommended in elderly patients with comorbidities and in patients with stage pT1/T2, pN0 and well differentiated (G1,G2) tumors.
- Open Access
- 1 January 2015
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 21 (17) , 5427-5431
Primary retroperitoneal mucinous cystadenoma: A case report
Primary retroperitoneal mucinous cystic tumors are extremely rare. These tumors can be classified as a primary retroperitoneal mucinous cystadenoma with or without borderline malignancy or primary retroperitoneal mucinous cystadenocarcinoma. The most common of these is primary retroperitoneal mucinous cystadenoma, which almost always occurs in female patients; only ten cases have been reported in males. The most common clinical findings for this tumor type include nonspecific abdominal pain and a palpable abdominal mass. A definitive diagnosis is usually obtained from histopathology after surgical excision. Here, we report the case of a 60-year-old female patient who complained of abdominal pain that had been present for 3 mo and presented with a palpable abdominal mass. Multidetector computed tomography scanning revealed a large, unilocular cystic mass in the left retroperitoneal space. Surgical intervention was performed and the tumor was completely removed. Histopathologic examination confirmed that the tumor was a primary retroperitoneal mucinous cystadenoma. Two years after surgery, the patient remains disease free.
- 1 January 2015
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 21 (17) , 5427-5431
Open AccessPrimary retroperitoneal mucinous cystadenoma: A case report
Primary retroperitoneal mucinous cystic tumors are extremely rare. These tumors can be classified as a primary retroperitoneal mucinous cystadenoma with or without borderline malignancy or primary retroperitoneal mucinous cystadenocarcinoma. The most common of these is primary retroperitoneal mucinous cystadenoma, which almost always occurs in female patients; only ten cases have been reported in males. The most common clinical findings for this tumor type include nonspecific abdominal pain and a palpable abdominal mass. A definitive diagnosis is usually obtained from histopathology after surgical excision. Here, we report the case of a 60-year-old female patient who complained of abdominal pain that had been present for 3 mo and presented with a palpable abdominal mass. Multidetector computed tomography scanning revealed a large, unilocular cystic mass in the left retroperitoneal space. Surgical intervention was performed and the tumor was completely removed. Histopathologic examination confirmed that the tumor was a primary retroperitoneal mucinous cystadenoma. Two years after surgery, the patient remains disease free.
- Open Access
- 1 January 2015
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 143 (3-4) , 195-198
Laparoscopic distal pancreatectomy for intrapancreatic accessory spleen: Case report
Introduction. Accessory spleens can be found in up to 10% of the population, and their intrapancreatic occurrence is considered uncommon. When present, the intrapancreatic accessory spleen is usually found in the tail of the pancreas in about 1.7% of adult individuals. The infrequent presence of the accessory spleen in the pancreatic tissue could lead to inappropriate diagnosis and hence therapeutic approach, as they are commonly presented as a hypervascular node in the tail of the pancreas on abdominal CT and MRI, mimicking a well differentiated tumor of the pancreas or non-functioning pancreatic neuroendocrine tumor. Case Outline. We present a 70-year-old female in whom a preoperative evaluation finding was highly suggestive of a non-functioning neuroendocrine tumor of the pancreatic tail. We performed spleen preserving laparoscopic distal pancreatectomy, and histopathological examination revealed the intrapancreatic accessory spleen. Conclusion. Although infrequent, the presence of the intrapancreatic accessory spleen must be considered in the differential diagnosis of pancreatic tail tumors.
- 1 January 2015
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 143 (3-4) , 195-198
Open AccessLaparoscopic distal pancreatectomy for intrapancreatic accessory spleen: Case report
Introduction. Accessory spleens can be found in up to 10% of the population, and their intrapancreatic occurrence is considered uncommon. When present, the intrapancreatic accessory spleen is usually found in the tail of the pancreas in about 1.7% of adult individuals. The infrequent presence of the accessory spleen in the pancreatic tissue could lead to inappropriate diagnosis and hence therapeutic approach, as they are commonly presented as a hypervascular node in the tail of the pancreas on abdominal CT and MRI, mimicking a well differentiated tumor of the pancreas or non-functioning pancreatic neuroendocrine tumor. Case Outline. We present a 70-year-old female in whom a preoperative evaluation finding was highly suggestive of a non-functioning neuroendocrine tumor of the pancreatic tail. We performed spleen preserving laparoscopic distal pancreatectomy, and histopathological examination revealed the intrapancreatic accessory spleen. Conclusion. Although infrequent, the presence of the intrapancreatic accessory spleen must be considered in the differential diagnosis of pancreatic tail tumors.
- Open Access
- 1 January 2014
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 20 (26) , 8691-9
Drain amylase value as an early predictor of pancreatic fistula after cephalic duodenopancreatectomy
To determine predictors of clinically relevant pancreatic fistulas (CRPF) by measuring drain fluid amylase (DFA) in the early postoperative period. This prospective clinical study included 382 patients with periampullary tumors that were surgically resected at our department between March 2005 and October 2012. A cephalic duodenopancreatectomy (DP) was performed on all patients. Two closed suction drains were placed at the end of the surgery. The highest postoperative DFA value was recorded and analyzed during the first three postoperative days and on subsequent days if the drains were kept longer. Pancreatic fistula (PF) was classified according to the International Study Group of Pancreatic Fistula (ISGPF) criteria. Postoperative complications were defined according to the Dindo-Clavien classification. All data were statistically analyzed. The optimal thresholds of DFA levels on the first, second and third postoperative days were estimated by constructing receiver operating curves, generated by calculating the sensitivities and specificities of the DFA levels. The DFA level limits were used to differentiate between the group without PF and the groups with biochemical pancreatic fistula (BPF) and CRPF. Pylorus-preserving duodenopancreatectomy was performed on 289 (75.6%) patients, while the remaining patients underwent a classic Whipple procedure (CW). The total incidence of PF was 37.7% (grade A 22.8%, grade B 11.0% and grade C 3.9%). Soft pancreatic texture (SPT) was present in 58.3% of patients who developed PF. Mortality was 4.2%. The median DFA value on the first postoperative day (DFA1) in patients who developed PF was 4520 U/L (range 350-99000 U/L) for grade A fistula (BPF) with a SPT and a diameter of the main pancreatic duct (MPD) of ≤ 3 mm. For grade B/C (CRPF), the median DFA1 value was 8501 U/L (range 377-92060 U/L) with a SPT and MPD of ≤ 3 mm. These values were significantly higher when compared to the patients who did not have PF (122; range 5-37875 U/L). The upper limit of DFA values for the first 3 postoperative days in the examined stages of PF were: DFA1 1200 U/L for the BPF and CRPF; DFA3 350 U/L for BPF and DFA3 800 U/L for CRPF. The determined values were highly significant and demonstrated a reliable diagnostic test for both BPF and CRPF. DFA1 ≥ 1200 U/L is an important predictive factor for PF of any degree. The trend of DFA3 (decrease of < 50%) compared to DFA1 is a significant factor in the differentiation of CRPF from transient BPF.
- 1 January 2014
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 20 (26) , 8691-9
Open AccessDrain amylase value as an early predictor of pancreatic fistula after cephalic duodenopancreatectomy
To determine predictors of clinically relevant pancreatic fistulas (CRPF) by measuring drain fluid amylase (DFA) in the early postoperative period. This prospective clinical study included 382 patients with periampullary tumors that were surgically resected at our department between March 2005 and October 2012. A cephalic duodenopancreatectomy (DP) was performed on all patients. Two closed suction drains were placed at the end of the surgery. The highest postoperative DFA value was recorded and analyzed during the first three postoperative days and on subsequent days if the drains were kept longer. Pancreatic fistula (PF) was classified according to the International Study Group of Pancreatic Fistula (ISGPF) criteria. Postoperative complications were defined according to the Dindo-Clavien classification. All data were statistically analyzed. The optimal thresholds of DFA levels on the first, second and third postoperative days were estimated by constructing receiver operating curves, generated by calculating the sensitivities and specificities of the DFA levels. The DFA level limits were used to differentiate between the group without PF and the groups with biochemical pancreatic fistula (BPF) and CRPF. Pylorus-preserving duodenopancreatectomy was performed on 289 (75.6%) patients, while the remaining patients underwent a classic Whipple procedure (CW). The total incidence of PF was 37.7% (grade A 22.8%, grade B 11.0% and grade C 3.9%). Soft pancreatic texture (SPT) was present in 58.3% of patients who developed PF. Mortality was 4.2%. The median DFA value on the first postoperative day (DFA1) in patients who developed PF was 4520 U/L (range 350-99000 U/L) for grade A fistula (BPF) with a SPT and a diameter of the main pancreatic duct (MPD) of ≤ 3 mm. For grade B/C (CRPF), the median DFA1 value was 8501 U/L (range 377-92060 U/L) with a SPT and MPD of ≤ 3 mm. These values were significantly higher when compared to the patients who did not have PF (122; range 5-37875 U/L). The upper limit of DFA values for the first 3 postoperative days in the examined stages of PF were: DFA1 1200 U/L for the BPF and CRPF; DFA3 350 U/L for BPF and DFA3 800 U/L for CRPF. The determined values were highly significant and demonstrated a reliable diagnostic test for both BPF and CRPF. DFA1 ≥ 1200 U/L is an important predictive factor for PF of any degree. The trend of DFA3 (decrease of < 50%) compared to DFA1 is a significant factor in the differentiation of CRPF from transient BPF.
- Open Access
- 12 June 2013
- Published by Walter de Gruyter GmbH in Open Medicine
- Vol. 8 (4) , 499-502
Progressive course of isolated splenic myeloid sarcoma
A previously healthy 40-year-old male presented with a 2-week history of fever and abdominal discomfort that was resistant to empirical broad-spectrum antibiotic treatment. The patient’s blood cell count and complete biochemical panel was normal, except for an increased lactate dehydrogenase level. Ultrasonography and computed tomography of the abdomen showed a large, soft tissue mass had infiltrated superior part of the spleen. Splenectomy with total tumor mass removal were performed. The pathological examination of the tumor tissue confirmed diagnosis of isolated myeloid sarcoma with monoblastic differentiation. Despite intensive antileukemic therapy, patient died four months after diagnosis was established.
- 12 June 2013
- Published by Walter de Gruyter GmbH in Open Medicine
- Vol. 8 (4) , 499-502
Open AccessProgressive course of isolated splenic myeloid sarcoma
A previously healthy 40-year-old male presented with a 2-week history of fever and abdominal discomfort that was resistant to empirical broad-spectrum antibiotic treatment. The patient’s blood cell count and complete biochemical panel was normal, except for an increased lactate dehydrogenase level. Ultrasonography and computed tomography of the abdomen showed a large, soft tissue mass had infiltrated superior part of the spleen. Splenectomy with total tumor mass removal were performed. The pathological examination of the tumor tissue confirmed diagnosis of isolated myeloid sarcoma with monoblastic differentiation. Despite intensive antileukemic therapy, patient died four months after diagnosis was established.
- 21 February 2012
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 27 (3) , 619
Hepatobiliary and Pancreatic: Pancreatic VIPomas associated with multiple endocrine neoplasia type I
- 21 February 2012
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 27 (3) , 619
Hepatobiliary and Pancreatic: Pancreatic VIPomas associated with multiple endocrine neoplasia type I
- 1 January 2008
- Vol. 14 (1) , CS5-8
Gastric multicentric glomangioma: a case report of this rare cause of abdominal pain.
A glomus tumor is a rare neoplasm derived from glomus cells, specialized cells that surround small blood vessels which are important in regulating peripheral blood flow. Glomangiomas are a subset of glomus tumors. They are usually localized in the skin and subcutaneous tissue. They have also been reported in viscera, most notably in the gastrointestinal tract. A case of gastric multicentric glomangioma is described in an 18-year-old male who presented with chronic continuous abdominal pain over a 4-6 month period. Preoperative diagnosis, operative findings, histology, and immunohistochemistry of the tumor are discussed in detail. Case reports of this rare tumor are important because of the paucity of studies noted in the gastro-intestinal literature as a result of poor identification prior to the advent of modern immunohistochemistry. The significance of accurately diagnosing a gastrointestinal glomangioma is crucial for appropriate treatment.
- 1 January 2008
- Vol. 14 (1) , CS5-8
Gastric multicentric glomangioma: a case report of this rare cause of abdominal pain.
A glomus tumor is a rare neoplasm derived from glomus cells, specialized cells that surround small blood vessels which are important in regulating peripheral blood flow. Glomangiomas are a subset of glomus tumors. They are usually localized in the skin and subcutaneous tissue. They have also been reported in viscera, most notably in the gastrointestinal tract. A case of gastric multicentric glomangioma is described in an 18-year-old male who presented with chronic continuous abdominal pain over a 4-6 month period. Preoperative diagnosis, operative findings, histology, and immunohistochemistry of the tumor are discussed in detail. Case reports of this rare tumor are important because of the paucity of studies noted in the gastro-intestinal literature as a result of poor identification prior to the advent of modern immunohistochemistry. The significance of accurately diagnosing a gastrointestinal glomangioma is crucial for appropriate treatment.